-
Meet the team: Part 3
Admescope welcomes Dr Laszlo Szilagyi, the newest member of the Business […]
-
Meet the team: Part 2
As part of our ‘meet the team’ series, Admescope welcomes Leah […]
-
MIST evaluation toolbox – what is in there? Part 4
The overall aim of the safety metabolism studies is to better […]
-
Welcome 2022!
Dear all, What a joy it is to address the Admescope […]
-
MIST evaluation toolbox – what is in there? Part 3
In the first part of this blog series, Dr Johanna Haglund […]
-
Preclinical characterisation of antibody-drug conjugates – ADME perspective
Antibody drug conjugate (ADC) comprise of a monoclonal antibody and cytotoxic […]
-
MIST evaluation toolbox – what is in there? Part 2
In Part 1, Dr Johanna Haglund (Head of Safety Metabolism) described […]
-
A new e-book is out and it’s all about biologics!
Admescope’s e-book series was launched in 2017 and the six e-books […]
-
MIST evaluation toolbox – what is in there? Part 1
Safety testing of drug metabolites is often discussed as ”MIST (metabolites […]
-
Twenty twenty, that was a plenty. Of everything.
Well yes, what a year it was, in joy and sorrow, […]
-
Glycoprofiling of antibodies – what, how and why?
Proteins go through various post-translational modifications (PTM) while produced by the […]
-
Optical tools for studying biomolecular interactions
Understanding binding specificity, affinity and kinetics is essential information when developing […]
Feel free to contact us!
Curious to know more about what can we do for you? Get in touch and let’s start a conversation.
